PRAEMIA HEALTHCARE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.01 EUR | -.--% |
|
-.--% | -.--% |
| 23/02 | Praemia Healthcare Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Praemia Healthcare Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 214.9 | 241 | 269.5 | 284.7 | 298 | 355.2 |
| EBITDA 1 | 200.4 | 223.4 | 249 | 263.5 | 272.3 | 290.6 |
| EBIT 1 | 102.9 | 115.6 | 135.1 | 145.1 | 272 | 289.5 |
| Operating Margin | 47.88% | 47.97% | 50.13% | 50.97% | 91.28% | 81.5% |
| Earnings before Tax (EBT) 1 | 72.8 | 66.3 | 92 | 82.9 | 491.9 | 384 |
| Net income 1 | 71.1 | 64.8 | 89.3 | 80 | 490.7 | 378.4 |
| Net margin | 33.09% | 26.89% | 33.14% | 28.1% | 164.66% | 106.53% |
| EPS 2 | 2.178 | 1.843 | 2.407 | 2.133 | 12.92 | 9.590 |
| Free Cash Flow | - | 28.02 | -45.71 | 45.99 | -147 | -27.91 |
| FCF margin | - | 11.63% | -16.96% | 16.15% | -49.34% | -7.86% |
| FCF Conversion (EBITDA) | - | 12.54% | - | 17.45% | - | - |
| FCF Conversion (Net income) | - | 43.25% | - | 57.48% | - | - |
| Dividend per Share 2 | 3.880 | 4.340 | 4.580 | 5.100 | 5.320 | 5.450 |
| Announcement Date | 17/02/20 | 17/02/20 | 17/02/20 | 22/02/21 | 21/02/22 | 01/03/23 |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1,316 | 1,420 | 1,689 | 1,845 | 2,066 | 2,085 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 6.564 x | 6.354 x | 6.784 x | 7.002 x | 7.586 x | 7.175 x |
| Free Cash Flow | - | 28 | -45.7 | 46 | -147 | -27.9 |
| ROE (net income / shareholders' equity) | - | 3.95% | 5.24% | 4.76% | 13.7% | 9.52% |
| ROA (Net income/ Total Assets) | - | 2.32% | 2.35% | 2.28% | 2.89% | 2.84% |
| Assets 1 | - | 2,795 | 3,795 | 3,514 | 17,005 | 13,339 |
| Book Value Per Share 2 | 48.90 | 47.90 | 45.80 | 43.20 | 95.30 | 102.0 |
| Cash Flow per Share 2 | 0.1300 | 2.160 | 11.30 | 12.40 | 2.060 | 9.170 |
| Capex 1 | 271 | 133 | 231 | 135 | 295 | 177 |
| Capex / Sales | 125.87% | 55.35% | 85.86% | 47.28% | 98.86% | 49.83% |
| Announcement Date | 17/02/20 | 17/02/20 | 17/02/20 | 22/02/21 | 21/02/22 | 01/03/23 |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- IS Stock
- Financials Praemia Healthcare
